VRelax

Self-management of stress and sleep disturbances with virtual reality relaxation for people with mood, anxiety or psychotic disorders

Purpose of the study

The effectiveness of adding VRelax to treatment as usual (TAU) in reducing psychiatric symptoms in patients with anxiety, depressive, bipolar or psychotic disorder compared to TAU only.

Website

Researchers

Dr. C.M.G. van Driel
Prof. dr. W. Veling
Dr. H.J.R. Hoenders
Drs. M. Jongma
Dr. M.L. Noordzij

Date

2020-09-01

- 2024-09-01

Participants

185 patients diagnosed with psychotic, anxiety, bipolar and depressive disorder.

Publications

Nijman et al 2022

Dynamic Interactive Social Cognition Training in Virtual Reality (DiSCoVR) versus Virtual Reality Relaxation (VRelax) for People With a Psychotic Disorder: A Single-Blind Multicenter Randomized Controlled Trial